Insider · CIK 0001190128
James R Tobin
director
Files at GMED (GLOBUS MEDICAL INC). First filing Sep 16, 2026, latest Sep 16, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $2.2M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GMED: GLOBUS MEDICAL INC
GMEDOct 9, 2026 · close 74.65
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | GMEDsell GLOBUS MEDICAL INC | $2.2M 30,000 shares | -100% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | GMED GLOBUS MEDICAL INC | MOption exercise Class A Common Stock | +15,000 | $53.75 | $806k | 15,000 | 25 d ago |
| Sep 15, 2026 | GMED GLOBUS MEDICAL INC | MOption exercise Class A Common Stock | +15,000 | $63.68 | $955k | 30,000 | 25 d ago |
| Sep 15, 2026 | GMED GLOBUS MEDICAL INC | SOpen-market sale Class A Common Stock | -30,000 | $74.58 | $2.2M | 0 | 25 d ago |
| Sep 15, 2026 | GMED GLOBUS MEDICAL INC | MOption exercise Stock Option (Right to Buy Class A Common Stock)derivative | -15,000 | $0.00 | $0 | 0 | 25 d ago |
| Sep 15, 2026 | GMED GLOBUS MEDICAL INC | MOption exercise Stock Option (Right to Buy Class A Common Stock)derivative | -15,000 | $0.00 | $0 | 0 | 25 d ago |
| Jan 23, 2025 | GMED GLOBUS MEDICAL INC | AGrant or award Stock Option (Right to Buy Class A Common Stock)derivative | +15,000 | $0.00 | $0 | 15,000 | Mar 28, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.